Vopratelimab

DB15378Investigational

Vopratelimab is under investigation in clinical trial NCT02904226 (JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors).

Mechanism: Pharmacologically active on Inducible T-cell costimulator
Curator reviewed
Code names: JTX-2011

Resolves to

Compound

UNIIQXN20J93AHCAS2039148-04-2

Targets

Q9Y6W8ICOS

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Vopratelimab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account